查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1617875

强度调控放射治疗市场：按适应症、放射类型和最终用户划分 - 2025-2030 年全球预测

Intensity Modulated Radiotherapy Market by Indication (Breast Cancer, Gastrointestinal Cancer, Gynecological Cancer), Radiation Type (Carbon-Ion Radiation, Electron Radiation, Photon Radiation), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

强度调控放射治疗市场2023年估值为23亿美元，预计2024年将达24.3亿美元，复合年增长率为5.36%，预计2030年将达33.2亿美元。

强度调控放射治疗(IMRT) 是一种用于癌症治疗的先进放射放射线治疗形式，可向恶性或肿瘤内的特定区域提供精确的放射治疗，同时最大限度地减少对周围正常组织的照射。对 IMRT 的需求源于其能够改善疗效和安全性之间的平衡、提高标靶准确性并减少癌症治疗中的附带损害。其应用范围广泛，用于多种癌症，包括摄护腺癌、头颈癌、妇科癌、肺癌、乳癌、胃肠道癌等。最终用途范围主要包括医院、癌症研究机构和专业放射治疗中心。

主要市场统计
基准年[2023] 23亿美元
预测年份 [2024] 24.3亿美元
预测年份 [2030] 33.2亿美元
复合年增长率（%） 5.36%

根据市场洞察，调强放射治疗的成长受到放射治疗技术进步、癌症盛行率增加以及对微创治疗方案需求不断增长的显着影响。最新的潜在机会在于人工智慧和机器学习的整合，以增强治疗计划和即时自适应放射治疗技术，质子和重离子治疗共用共生创新的潜力。抓住这些机会需要对研发进行投资，并与高科技公司建立策略合作伙伴关係，为下一代放射治疗解决方案铺路。

然而，限制因素包括缺乏有效实施调强放射治疗的熟练专业人员，以及设备高成本，限制了其在新兴市场的部署。此外，技术创新的快速发展需要持续的培训和教育，这可能是资源密集的。监管障碍和报销问题也带来了挑战，特别是在卫生基础设施欠发达的地区。在技​​术创新方面，专注于具有成本效益的治疗提供模式、扩大远端医疗服务以及开发可携式放射治疗系统以实现更广泛的普及可以提供可行的成长路径。该市场的特点是高投资需求和快速的技术变革，使其既是充满活力的创新途径，也是新参与企业的巨大进入障碍。

市场动态：揭示快速发展的强度调控放射治疗市场的关键市场洞察

供需的动态交互作用正在改变强度调控放射治疗市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助消费行为及其对製造业的影响。

  • 市场驱动因素
    • 全球癌症发生率增加
    • 政府不断加强癌症控制倡议
    • 全球卫生支出增加
  • 市场限制因素
    • 癌症治疗费用上涨
  • 市场机会
    • 强度调控放射治疗的持续创新
    • 扩大癌症领域创新疗法的采用
  • 市场问题
    • 缺乏熟练的专业人员

波特五力：驾驭调强度调控放射治疗市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架描述了评估公司竞争和探索策略机会的清晰方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点，避免潜在的挑战，确保更强大的市场地位。

PESTLE分析：了解强度调控放射治疗市场的外在影响

外部宏观环境因素在塑造强度调控放射治疗市场的绩效动态发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析：了解强度调控放射治疗市场的竞争格局

强度调控放射治疗市场的详细市场占有率分析可以对供应商的表现进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、细分和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵：强度调控放射治疗市场供应商的绩效评估

FPNV 定位矩阵是评估强度调控放射治疗市场供应商的关键工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议：制定调强度调控放射治疗市场的成功之路

对于旨在加强在全球市场的影响力的公司来说，调强强度调控放射治疗市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

该报告对涵盖关键焦点细分市场的市场进行了全面分析。

1.市场渗透率：对当前市场环境的详细审查，主要企业的广泛资料，评估他们在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有细分市场的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策。

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品和地区提供最佳投资机会？

3.塑造市场的关键技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 全球癌症发生率增加
      • 政府加大癌症控制力道
      • 全球医疗费用上涨
    • 抑制因素
      • 癌症治疗费用高昂
    • 机会
      • 强度调控放射治疗的持续创新
      • 扩大在肿瘤领域引入创新疗法
    • 任务
      • 缺乏熟练的专业人员
  • 市场区隔分析
    • 适应症：扩大调强放射治疗（IMRT）的应用，减少各种适应症的副作用，提升患者的生活品质
    • 放射类型：多用途光子疗法首选治疗各种肿瘤大小、位置和阶段
    • 最终用户：财力雄厚的医院越来越多地采用最新创新技术
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 经济
    • 社会
    • 科技
    • 法律
    • 环境

第六章强度调控放射治疗市场：依适应症分类

  • 介绍
  • 乳癌
  • 消化道癌症
  • 妇科癌症
  • 肺癌
  • 摄护腺癌

第七章强度调控放射治疗市场：依放射线类型

  • 介绍
  • 碳离子辐射
  • 电子辐射
  • 光子辐射
  • 质子辐射

第八章强度调控放射治疗市场：依最终使用者分类

  • 介绍
  • 医院
  • 独立放射治疗中心

第九章北美及南美强度调控放射治疗市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太强度调控放射治疗市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲、中东和非洲强度调控放射治疗市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • M42 与 QST 签署协议共用碳离子疗法研究
    • IBA 与阿波罗质子癌症中心独家合作，为全球肿瘤学家提供质子治疗培训
    • 英国首个乳癌质子束治疗检验开始
  • 战略分析和建议

公司名单

  • Accuray Incorporated
  • Aetna Inc.
  • Brainlab AG
  • Elekta AB
  • GE Healthcare
  • Hitachi, Ltd.
  • Mevion Medical Systems
  • PMB by ALCEN group
  • Siemens Healthineers AG
  • Varian Medical Systems, Inc.
  • Xstrahl Group
Product Code: MRR-CF6C60CF95AB

The Intensity Modulated Radiotherapy Market was valued at USD 2.30 billion in 2023, expected to reach USD 2.43 billion in 2024, and is projected to grow at a CAGR of 5.36%, to USD 3.32 billion by 2030.

Intensity Modulated Radiotherapy (IMRT) is an advanced form of radiation therapy used in cancer treatment that focuses on delivering precise radiation doses to a malignant tumor or specific areas within the tumor while minimizing exposure to the surrounding normal tissues. The necessity of IMRT stems from its ability to improve targeting accuracy and reduce collateral damage, enhancing the balance between efficacy and safety in cancer therapeutics. Its application is extensive, being used for various types of cancer, including prostate, head and neck, gynecological, lung, breast, and gastrointestinal cancers. The end-use scope predominantly includes hospitals, cancer research institutes, and specialized radiotherapy centers.

KEY MARKET STATISTICS
Base Year [2023] USD 2.30 billion
Estimated Year [2024] USD 2.43 billion
Forecast Year [2030] USD 3.32 billion
CAGR (%) 5.36%

Market insights indicate that the growth of IMRT is significantly influenced by technological advancements in radiation therapy, increasing prevalence of cancer, and rising demand for less invasive treatment options. The latest potential opportunities lie in the integration of AI and machine learning to enhance treatment planning and real-time adaptive radiotherapy techniques, alongside possible developments in proton and heavy ion therapy, which share symbiotic technological innovations with IMRT. To seize these opportunities, investments in research and development are essential, along with strategic partnerships with tech companies to pave the way for next-generation radiotherapy solutions.

However, the market faces limitations such as the high cost of equipment, which restricts adoption in developing regions, alongside a scarcity of skilled professionals to effectively implement IMRT procedures. Additionally, the rapid pace of innovation necessitates continuous training and education, which can be resource-intensive. Challenges also include regulatory hurdles and reimbursement issues, particularly in regions with less established healthcare infrastructures. In terms of innovation, focusing on cost-effective treatment delivery models, expanding teletherapy services, and developing portable IMRT systems for broader access could offer viable growth pathways. The market is predominantly characterized by high investment needs and rapid technological transitions, presenting both a vibrant avenue for innovation and substantial entry barriers for new players.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Intensity Modulated Radiotherapy Market

The Intensity Modulated Radiotherapy Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing incidences of cancer across the world
    • Rise in government initiatives for cancer management
    • Increase in healthcare expenditure globally
  • Market Restraints
    • High cost of cancer treatment
  • Market Opportunities
    • Ongoing innovation in Intensity Modulated Radiotherapy
    • Growing adoption of innovative treatment in the oncology field
  • Market Challenges
    • Shortage of skilled professionals

Porter's Five Forces: A Strategic Tool for Navigating the Intensity Modulated Radiotherapy Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Intensity Modulated Radiotherapy Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Intensity Modulated Radiotherapy Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Intensity Modulated Radiotherapy Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Intensity Modulated Radiotherapy Market

A detailed market share analysis in the Intensity Modulated Radiotherapy Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Intensity Modulated Radiotherapy Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Intensity Modulated Radiotherapy Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Intensity Modulated Radiotherapy Market

A strategic analysis of the Intensity Modulated Radiotherapy Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Intensity Modulated Radiotherapy Market, highlighting leading vendors and their innovative profiles. These include Accuray Incorporated, Aetna Inc., Brainlab AG, Elekta AB, GE Healthcare, Hitachi, Ltd., Mevion Medical Systems, PMB by ALCEN group, Siemens Healthineers AG, Varian Medical Systems, Inc., and Xstrahl Group.

Market Segmentation & Coverage

This research report categorizes the Intensity Modulated Radiotherapy Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Indication, market is studied across Breast Cancer, Gastrointestinal Cancer, Gynecological Cancer, Lung Cancer, and Prostate Cancer.
  • Based on Radiation Type, market is studied across Carbon-Ion Radiation, Electron Radiation, Photon Radiation, and Proton Radiation.
  • Based on End-User, market is studied across Hospitals and Independent Radiotherapy Centers.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing incidences of cancer across the world
      • 5.1.1.2. Rise in government initiatives for cancer management
      • 5.1.1.3. Increase in healthcare expenditure globally
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of cancer treatment
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing innovation in Intensity Modulated Radiotherapy
      • 5.1.3.2. Growing adoption of innovative treatment in the oncology field
    • 5.1.4. Challenges
      • 5.1.4.1. Shortage of skilled professionals
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Indication: Growing applications of IMRT for reduced side effects and enhanced quality of patient life across various indications
    • 5.2.2. Radiation Type: Higher preferences for versatile photon therapy to treat various tumor sizes, locations, and stages
    • 5.2.3. End-User: Rising adoption by hospitals with greater financial resources to invest in the latest innovations
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Intensity Modulated Radiotherapy Market, by Indication

  • 6.1. Introduction
  • 6.2. Breast Cancer
  • 6.3. Gastrointestinal Cancer
  • 6.4. Gynecological Cancer
  • 6.5. Lung Cancer
  • 6.6. Prostate Cancer

7. Intensity Modulated Radiotherapy Market, by Radiation Type

  • 7.1. Introduction
  • 7.2. Carbon-Ion Radiation
  • 7.3. Electron Radiation
  • 7.4. Photon Radiation
  • 7.5. Proton Radiation

8. Intensity Modulated Radiotherapy Market, by End-User

  • 8.1. Introduction
  • 8.2. Hospitals
  • 8.3. Independent Radiotherapy Centers

9. Americas Intensity Modulated Radiotherapy Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Intensity Modulated Radiotherapy Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Intensity Modulated Radiotherapy Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. M42 and QST Sign Agreement to Share Research on Carbon Ion Therapy
    • 12.3.2. IBA Partners Exclusively with Apollo Proton Cancer Centre for Providing Proton Beam Therapy Training to Oncologists from Across the Globe
    • 12.3.3. First UK Proton Beam Therapy Trial for Breast Cancer Launches
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Accuray Incorporated
  • 2. Aetna Inc.
  • 3. Brainlab AG
  • 4. Elekta AB
  • 5. GE Healthcare
  • 6. Hitachi, Ltd.
  • 7. Mevion Medical Systems
  • 8. PMB by ALCEN group
  • 9. Siemens Healthineers AG
  • 10. Varian Medical Systems, Inc.
  • 11. Xstrahl Group

LIST OF FIGURES

  • FIGURE 1. INTENSITY MODULATED RADIOTHERAPY MARKET RESEARCH PROCESS
  • FIGURE 2. INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. INTENSITY MODULATED RADIOTHERAPY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. INTENSITY MODULATED RADIOTHERAPY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. INTENSITY MODULATED RADIOTHERAPY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. INTENSITY MODULATED RADIOTHERAPY MARKET DYNAMICS
  • TABLE 7. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY GASTROINTESTINAL CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY GYNECOLOGICAL CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY CARBON-ION RADIATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY ELECTRON RADIATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY PHOTON RADIATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY PROTON RADIATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDEPENDENT RADIOTHERAPY CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 46. AUSTRALIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. AUSTRALIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 49. CHINA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. CHINA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 52. INDIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. INDIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 55. INDONESIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. INDONESIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 58. JAPAN INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. JAPAN INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 61. MALAYSIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. MALAYSIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 64. PHILIPPINES INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. PHILIPPINES INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 67. SINGAPORE INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. SINGAPORE INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 70. SOUTH KOREA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. SOUTH KOREA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 73. TAIWAN INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. TAIWAN INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 76. THAILAND INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. THAILAND INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 79. VIETNAM INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. VIETNAM INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 86. DENMARK INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. DENMARK INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 89. EGYPT INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. EGYPT INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 92. FINLAND INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. FINLAND INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 95. FRANCE INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. FRANCE INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 98. GERMANY INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. GERMANY INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 101. ISRAEL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. ISRAEL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 104. ITALY INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. ITALY INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 107. NETHERLANDS INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. NETHERLANDS INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 110. NIGERIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. NIGERIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 113. NORWAY INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. NORWAY INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 116. POLAND INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. POLAND INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 119. QATAR INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. QATAR INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 122. RUSSIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. RUSSIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 125. SAUDI ARABIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. SAUDI ARABIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH AFRICA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH AFRICA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 131. SPAIN INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. SPAIN INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 134. SWEDEN INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. SWEDEN INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 137. SWITZERLAND INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. SWITZERLAND INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 140. TURKEY INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. TURKEY INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED ARAB EMIRATES INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED ARAB EMIRATES INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED KINGDOM INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED KINGDOM INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 148. INTENSITY MODULATED RADIOTHERAPY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 149. INTENSITY MODULATED RADIOTHERAPY MARKET, FPNV POSITIONING MATRIX, 2023